Evaluation of “Tumor Necrosis Factor-Alpha for Rheumatoid Arthritis Patients” in Karbala Population
Medical Journal of Babylon · 2026-04 · 23 (2) · 1011-1014
DOI: 10.4103/mjbl.mjbl_995_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Babylon, online erschienen am 18.08.2026. Verfasst von Roaa Noori Ali und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Rheumatoid arthritis (RA) refers to a persistent disease characterized by inflammation and gradual deterioration of the joints. Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine that plays a crucial role in controlling the inflammatory response in joint diseases such as RA and another autoimmune disease. TNF-α in particular plays a significant role in the pathogenesis of RA disease and is connected to inflammation of the joint.
Objectives
The aim of this research was to evaluate the serum TNF-α in RA patients. Materials and Methods: “Case–control” study was performed to involve 150 subjects. The sample of serum was taken from three groups, the first group was the patients with early diagnosis RA, the second group were under treatment patients with RA, and healthy participants made up the third group. The serum of this sample used to identify TNF-α was assessed using the enzyme-linked immunosorbent assay technique.
Result
Our analyses revealed the level of serum TNF-α in patients undergoing treatment for RA (12.31 ± 0.85) compared to the control group (11.89 ± 1.19) increased significantly ( P = 0.034). However, the value between RA treatment 12.31 ± 0.85 and early diagnosis RA 12.21 ± 0.82 show non-significant differences ( P = 0.614). Also, the value between healthy control group and early diagnosis RA group shows non-significant differences ( P = 0.104).
Conclusion
According to the results of the current study show, the patients with RA under treatment had significantly higher levels of the TNF-α in serum.
Zitieren
APA
Ali, R. N., & Shaheed, O. M. (2026). Evaluation of “Tumor Necrosis Factor-Alpha for Rheumatoid Arthritis Patients” in Karbala Population. Medical Journal of Babylon, 23(2), 1011-1014. https://doi.org/10.4103/mjbl.mjbl_995_23
Vancouver
Ali RN, Shaheed OM. Evaluation of “Tumor Necrosis Factor-Alpha for Rheumatoid Arthritis Patients” in Karbala Population. Medical Journal of Babylon. 2026;23(2):1011-1014. doi:10.4103/mjbl.mjbl_995_23
BibTeX
@article{Ali2026,
author = {Ali, Roaa Noori and Shaheed, Orass Madhi},
title = {Evaluation of “Tumor Necrosis Factor-Alpha for Rheumatoid Arthritis Patients” in Karbala Population},
journal = {Medical Journal of Babylon},
year = {2026},
volume = {23},
number = {2},
pages = {1011--1014},
doi = {10.4103/mjbl.mjbl_995_23}
}
EUVIMED